Temasek backs $55m Series A for US-based RNA gene therapy startup Locana

Locana, a California-based RNA-targeting gene therapy startup, has raised $55 million in its Series A funding round backed by existing investor Temasek Holdings, Singapore’s state-owned investment firm, according to an announcement.